«The burden of illness of irritable bowel syndrome: current challenges and hope for the future». Journal of Managed Care Pharmacy, vol. 10, 4, 2004, pàg. 299–309. DOI: 10.18553/jmcp.2004.10.4.299. PMC: 10437478. PMID: 15298528.
«The role of stress on physiologic responses and clinical symptoms in irritable bowel syndrome». Gastroenterology, vol. 140, 3, 3-2011, pàg. 761–5. DOI: 10.1053/j.gastro.2011.01.032. PMC: 3039211. PMID: 21256129.
«Human Milk Oligosaccharides Support Normal Bowel Function and Improve Symptoms of Irritable Bowel Syndrome: A Multicenter, Open-Label Trial». Clinical and Translational Gastroenterology, vol. 11, 12, 12-2020, pàg. e00276. DOI: 10.14309/ctg.0000000000000276. PMC: 7721220. PMID: 33512807.
«The effect of fiber supplementation on irritable bowel syndrome: a systematic review and meta-analysis». The American Journal of Gastroenterology, vol. 109, 9, 9-2014, pàg. 1367–1374. DOI: 10.1038/ajg.2014.195. PMID: 25070054.
«Systematic review: dietary fibre and FODMAP-restricted diet in the management of constipation and irritable bowel syndrome». Alimentary Pharmacology & Therapeutics, vol. 41, 12, 6-2015, pàg. 1256–70. DOI: 10.1111/apt.13167. PMID: 25903636.
«Global prevalence of and risk factors for irritable bowel syndrome: a meta-analysis». Clinical Gastroenterology and Hepatology, vol. 10, 7, 7-2012, pàg. 712–721.e4. DOI: 10.1016/j.cgh.2012.02.029. PMID: 22426087. «Pooled prevalence in all studies was 11.2% (95% CI, 9.8%-12.8%). The prevalence varied according to country (from 1.1% to 45.0%) and criteria used to define IBS... Women are at slightly higher risk for IBS than men.»
«Is there true gender difference of irritable bowel syndrome in Asia?». Journal of Neurogastroenterology and Motility, vol. 17, 2, 4-2011, pàg. 206–207. DOI: 10.5056/jnm.2011.17.2.206. PMC: 3093021. PMID: 21603006. "However, some Asian studies fail to report significant gender differences in the prevalence of IBS.6"
«The epidemiology of irritable bowel syndrome». Clinical Epidemiology, vol. 6, 04-02-2014, pàg. 71–80. DOI: 10.2147/CLEP.S40245. PMC: 3921083. PMID: 24523597. "In South Asia, South America, and Africa, rates of IBS in men are much closer to those of women, and in some cases higher. Consequently, if prevalence is stratified according to geographic region, no significant sex difference can be seen in these areas.80"
«Effect of fibre, antispasmodics, and peppermint oil in the treatment of irritable bowel syndrome: systematic review and meta-analysis». BMJ, vol. 337, 11-2008, pàg. a2313. DOI: 10.1136/bmj.a2313. PMC: 2583392. PMID: 19008265.
«Effect of antidepressants and psychological therapies, including hypnotherapy, in irritable bowel syndrome: systematic review and meta-analysis». The American Journal of Gastroenterology, vol. 109, 9, 9-2014, pàg. 1350–65; quiz 1366. DOI: 10.1038/ajg.2014.148. PMID: 24935275.
«Peppermint oil for the treatment of irritable bowel syndrome: a systematic review and meta-analysis». Journal of Clinical Gastroenterology, vol. 48, 6, 7-2014, pàg. 505–12. DOI: 10.1097/MCG.0b013e3182a88357. PMID: 24100754.
«Systematic review: the role of different types of fibre in the treatment of irritable bowel syndrome». Alimentary Pharmacology & Therapeutics, vol. 19, 3, 2-2004, pàg. 245–51. DOI: 10.1111/j.0269-2813.2004.01862.x. PMID: 14984370.
«A practical guide to the proper prescription of physical activity in patients with irritable bowel syndrome». Digestive and Liver Disease, vol. 54, 11, 2022, pàg. 1600–1604. DOI: 10.1016/j.dld.2022.08.034. PMID: 36153192.
«British Society of Gastroenterology guidelines on the management of irritable bowel syndrome». Gut, vol. 70, 7, 2021, pàg. 1214–1240. DOI: 10.1136/gutjnl-2021-324598. PMID: 33903147.
«ACG Clinical Guideline: Management of Irritable Bowel Syndrome». American Journal of Gastroenterology, vol. 116, 1, 2021, pàg. 17–44. DOI: 10.14309/ajg.0000000000001036. PMID: 33315591.
«Bulking agents, antispasmodics and antidepressants for the treatment of irritable bowel syndrome». The Cochrane Database of Systematic Reviews, vol. 2013, 8, 8-2011, pàg. CD003460. DOI: 10.1002/14651858.CD003460.pub3. PMC: 8745618. PMID: 21833945.
«Small Intestinal Bacterial Overgrowth and Irritable Bowel Syndrome: A Bridge between Functional Organic Dichotomy». Gut and Liver, vol. 11, 2, 3-2017, pàg. 196–208. DOI: 10.5009/gnl16126. PMC: 5347643. PMID: 28274108.
«Systematic review with meta-analysis: the efficacy of prebiotics, probiotics, synbiotics and antibiotics in irritable bowel syndrome». Alimentary Pharmacology & Therapeutics, vol. 48, 10, 11-2018, pàg. 1044–1060. DOI: 10.1111/apt.15001. PMID: 30294792.
«Efficacy of probiotics in irritable bowel syndrome: a meta-analysis of randomized, controlled trials». Diseases of the Colon and Rectum, vol. 51, 12, 12-2008, pàg. 1775–80. DOI: 10.1007/s10350-008-9335-z. PMID: 18465170.
«The burden of illness of irritable bowel syndrome: current challenges and hope for the future». Journal of Managed Care Pharmacy, vol. 10, 4, 2004, pàg. 299–309. DOI: 10.18553/jmcp.2004.10.4.299. PMC: 10437478. PMID: 15298528.
«The role of stress on physiologic responses and clinical symptoms in irritable bowel syndrome». Gastroenterology, vol. 140, 3, 3-2011, pàg. 761–5. DOI: 10.1053/j.gastro.2011.01.032. PMC: 3039211. PMID: 21256129.
«Human Milk Oligosaccharides Support Normal Bowel Function and Improve Symptoms of Irritable Bowel Syndrome: A Multicenter, Open-Label Trial». Clinical and Translational Gastroenterology, vol. 11, 12, 12-2020, pàg. e00276. DOI: 10.14309/ctg.0000000000000276. PMC: 7721220. PMID: 33512807.
«The effect of fiber supplementation on irritable bowel syndrome: a systematic review and meta-analysis». The American Journal of Gastroenterology, vol. 109, 9, 9-2014, pàg. 1367–1374. DOI: 10.1038/ajg.2014.195. PMID: 25070054.
«Systematic review: dietary fibre and FODMAP-restricted diet in the management of constipation and irritable bowel syndrome». Alimentary Pharmacology & Therapeutics, vol. 41, 12, 6-2015, pàg. 1256–70. DOI: 10.1111/apt.13167. PMID: 25903636.
«Global prevalence of and risk factors for irritable bowel syndrome: a meta-analysis». Clinical Gastroenterology and Hepatology, vol. 10, 7, 7-2012, pàg. 712–721.e4. DOI: 10.1016/j.cgh.2012.02.029. PMID: 22426087. «Pooled prevalence in all studies was 11.2% (95% CI, 9.8%-12.8%). The prevalence varied according to country (from 1.1% to 45.0%) and criteria used to define IBS... Women are at slightly higher risk for IBS than men.»
«Is there true gender difference of irritable bowel syndrome in Asia?». Journal of Neurogastroenterology and Motility, vol. 17, 2, 4-2011, pàg. 206–207. DOI: 10.5056/jnm.2011.17.2.206. PMC: 3093021. PMID: 21603006. "However, some Asian studies fail to report significant gender differences in the prevalence of IBS.6"
«The epidemiology of irritable bowel syndrome». Clinical Epidemiology, vol. 6, 04-02-2014, pàg. 71–80. DOI: 10.2147/CLEP.S40245. PMC: 3921083. PMID: 24523597. "In South Asia, South America, and Africa, rates of IBS in men are much closer to those of women, and in some cases higher. Consequently, if prevalence is stratified according to geographic region, no significant sex difference can be seen in these areas.80"
«Effect of fibre, antispasmodics, and peppermint oil in the treatment of irritable bowel syndrome: systematic review and meta-analysis». BMJ, vol. 337, 11-2008, pàg. a2313. DOI: 10.1136/bmj.a2313. PMC: 2583392. PMID: 19008265.
«Effect of antidepressants and psychological therapies, including hypnotherapy, in irritable bowel syndrome: systematic review and meta-analysis». The American Journal of Gastroenterology, vol. 109, 9, 9-2014, pàg. 1350–65; quiz 1366. DOI: 10.1038/ajg.2014.148. PMID: 24935275.
«Peppermint oil for the treatment of irritable bowel syndrome: a systematic review and meta-analysis». Journal of Clinical Gastroenterology, vol. 48, 6, 7-2014, pàg. 505–12. DOI: 10.1097/MCG.0b013e3182a88357. PMID: 24100754.
«Systematic review: the role of different types of fibre in the treatment of irritable bowel syndrome». Alimentary Pharmacology & Therapeutics, vol. 19, 3, 2-2004, pàg. 245–51. DOI: 10.1111/j.0269-2813.2004.01862.x. PMID: 14984370.
«A practical guide to the proper prescription of physical activity in patients with irritable bowel syndrome». Digestive and Liver Disease, vol. 54, 11, 2022, pàg. 1600–1604. DOI: 10.1016/j.dld.2022.08.034. PMID: 36153192.
«British Society of Gastroenterology guidelines on the management of irritable bowel syndrome». Gut, vol. 70, 7, 2021, pàg. 1214–1240. DOI: 10.1136/gutjnl-2021-324598. PMID: 33903147.
«ACG Clinical Guideline: Management of Irritable Bowel Syndrome». American Journal of Gastroenterology, vol. 116, 1, 2021, pàg. 17–44. DOI: 10.14309/ajg.0000000000001036. PMID: 33315591.
«Bulking agents, antispasmodics and antidepressants for the treatment of irritable bowel syndrome». The Cochrane Database of Systematic Reviews, vol. 2013, 8, 8-2011, pàg. CD003460. DOI: 10.1002/14651858.CD003460.pub3. PMC: 8745618. PMID: 21833945.
«Small Intestinal Bacterial Overgrowth and Irritable Bowel Syndrome: A Bridge between Functional Organic Dichotomy». Gut and Liver, vol. 11, 2, 3-2017, pàg. 196–208. DOI: 10.5009/gnl16126. PMC: 5347643. PMID: 28274108.
«Systematic review with meta-analysis: the efficacy of prebiotics, probiotics, synbiotics and antibiotics in irritable bowel syndrome». Alimentary Pharmacology & Therapeutics, vol. 48, 10, 11-2018, pàg. 1044–1060. DOI: 10.1111/apt.15001. PMID: 30294792.
«Efficacy of probiotics in irritable bowel syndrome: a meta-analysis of randomized, controlled trials». Diseases of the Colon and Rectum, vol. 51, 12, 12-2008, pàg. 1775–80. DOI: 10.1007/s10350-008-9335-z. PMID: 18465170.
«Diagnosis and management of IBS in adults». American Family Physician, vol. 86, 5, 9-2012, pàg. 419–26. PMID: 22963061.
